DAAN Biotherapeutics and GC Cell partner for CAR-T, CAR-NK therapies
The deal between the companies includes upfront and milestone payments, as well as royalties on future sales.
Cytiva Pipe dream to pipeline WP 3
Atsena closes $150m in Series C round to progress gene therapy
Alltrna plans to tackle rare diseases using tRNA-based therapies
Struggling bluebird bio to go private for less than $30m
Pfizer shelves haemophilia gene therapy Beqvez amid low demand
FDA grants fast track status to Rznomics’ RZ-001 for HCC
SmartCella gains rights to advance cell therapy research for Parkinson’s
Italian charity seeks EMA approval for rescued gene therapy
